Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.

Various parameters will be assessed during the procedure before and after 1 hour of 12.5 mg carvedilol such as HVPG (WHVP - FHVP), SVR, heart rate, cardiac output, cardiac index, Blood pressure

  • 0 views
  • 26 Mar, 2022
  • 1 location
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to

hormone therapy
ceritinib
human epidermal growth factor
beta blockers
step 2
  • 286 views
  • 26 Feb, 2022
  • 114 locations
Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

increase in life expectancy. Carvedilol is an and -blocker that also has antioxidant properties. Preliminary studies have shown that carvedilol and its metabolites prevent lipid peroxidation, inhibit the

treatment regimen
primary cancer
anthracyclines
  • 0 views
  • 08 Oct, 2021
  • 1 location
Beta-blockers for Oesophageal Varices

To determine if carvedilol reduces the rate of variceal haemorrhage in patients with cirrhosis and small oesophageal varices

  • 0 views
  • 24 Jan, 2021
  • 3 locations
Carvedilol for Prevention of Esophageal Varices Progression (Carvedilol)

Carvedilol has been shown to be more potent in decreasing portal hypertension to propranolol. But the efficacy of carvedilol to delay the growth of esophageal varices in chronic hepatitis B

propranolol
hepatitis
varicose veins
esophageal varices
antiviral drugs
  • 4 views
  • 24 Mar, 2022
  • 6 locations
TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC)

cardiovascular protective strategies, e.g. with a beta-blocker, could help. This study randomly assigns those taking curative-intent trastuzumab-based HER2-directed therapy to the beta-blocker carvedilol-either

lapatinib
mammogram
HER2
her2/neu-positive breast cancer
trastuzumab
  • 1 views
  • 21 Mar, 2022
  • 3 locations
Extension Study of Carvedilol RCT Study

Patients who have completed 2-years treatment in RCT Study of carvedilol will receive another 2-years extension therapy, aiming to investigate the long-term efficacy of carvedilol for the

esophageal varices
carvedilol
  • 0 views
  • 01 Sep, 2021
  • 14 locations
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension (Betastatin)

Patients with hepatic cirrhosis and previous variceal bleeding will be randomly assigned to use propranolol or carvedilol. After 8 weeks, rosuvastatin or placebo will be blindly added to

propranolol
cirrhosis
hypertension
carvedilol
  • 2 views
  • 01 Feb, 2022
  • 1 location
Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

The cumulative risk of refractory ascites is in the order of 20% within five years of the development of ascites. An elevated sinusoidal pressure is essential for the development of ascites, as fluid accumulation does not develop at portal pressure gradient below 8 mm Hg, and rising corrected sinusoidal pressure …

ascites
spontaneous bacterial peritonitis
hypertension
vasodilatation
vasopressin
  • 0 views
  • 06 Nov, 2021
  • 1 location
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding

Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

  • 0 views
  • 25 Jan, 2021
  • 1 location